An Observational Study of Subcutaneous Infusion of ABBV-951 to Assess Change in Disease Activity and Adverse Events In Adult Japanese Participants With Advanced Parkinson's Disease

RecruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

November 30, 2023

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Parkinson's Disease (PD)
Trial Locations (16)

791-8026

RECRUITING

Saiseikai Matsuyama Hospital /ID# 276259, Matsuyama

070-0901

RECRUITING

National Hospital Organization Asahikawa Medical Center /ID# 269115, Asahikawa

305-0854

RECRUITING

Ryugasaki Saiseikai Hospital /ID# 264435, Ryūgasaki

305-8576

RECRUITING

University of Tsukuba Hospital /ID# 268353, Tsukuba

890-0067

RECRUITING

Okatsu Hospital /ID# 262781, Kagoshima

602-8566

RECRUITING

University Hospital Kyoto Prefectural University of Medicine /ID# 267445, Kyoto

982-8555

RECRUITING

Sendai Nishitaga National Hospital /ID# 268349, Sendai

885-0055

RECRUITING

Fujimoto General Hospital /ID# 277287, Miyakonojo-shi

520-2192

RECRUITING

Shiga University of Medical Science Hospital /ID# 265637, Ōtsu

321-0293

RECRUITING

Dokkyo Medical University Hospital /ID# 269116, Mibu

113-8431

RECRUITING

Juntendo University Hospital /ID# 264438, Bunkyo-ku

164-0011

RECRUITING

Nitobe Memorial Nakano General Hospital /ID# 275668, Nakano-ku

187-8551

RECRUITING

National Center of Neurology and Psychiatry - Kodaira /ID# 267372, Xiaoping City

616-8255

RECRUITING

National Hospital Organization Utano Hospital /ID# 268350, Kyoto

702-8005

RECRUITING

Okayama Neurology Clinic /ID# 269117, Okayama

560-0055

RECRUITING

Municipal Toyonaka Hospital /ID# 271277, Toyonaka

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY